SKYE BIOSCIENCE INC News

Skye Bioscience, Inc.'s (NASDAQ:SKYE) Last Week's 13% Decline Must Have Disappointed Private Equity Firms Who Have a Significant Stake

Yahoo FinanceMay 12 08:46 ET

Express News | Skye Bioscience Inc Files For Mixed Shelf Of Up To $300M - Sec Filing

BenzingaMay 10 16:31 ET

Express News | Skye Bioscience Inc Files for Mixed Shelf of up to $300 Mln - SEC Filing

ReutersMay 10 16:20 ET

SKYE BIOSCIENCE INC | 10-Q: Quarterly report

Futu NewsMay 10 16:06 ET · Announcements

Express News | Skye Bioscience Presents Novel Synthetic Cannabinoid-based Library Capable Of Modulating The Endocannabinoid System To Treat Ocular Diseases At ARVO 2024 Annual Meeting

BenzingaMay 10 07:47 ET

Skye Bioscience Highlights Novel Synthetic Cannabinoid-based Library Capable of Modulating the Endocannabinoid System to Treat Ocular Diseases at ARVO 2024 Annual Meeting

SAN DIEGO, May 10, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (NASDAQ:SKYE) ("Skye"), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel classes of

GlobeNewswireMay 10 07:00 ET

Skye Bioscience Moves to Nasdaq, Hits Milestone in Clinical Program | NASDAQ:SKYE

Proactive InvestorsMay 6 08:27 ET

12 Health Care Stocks Moving In Thursday's Pre-Market Session

GainersAllarity Therapeutics (NASDAQ:ALLR) stock moved upwards by 106.6% to $2.83 during Thursday's pre-market session. The market value of their outstanding shares is at $5.5 million. Emergent BioSol

BenzingaMay 2 08:06 ET

Skye Bioscience to Present Two Posters at Association for Research in Vision and Ophthalmology (ARVO) 2024 Annual Meeting

SAN DIEGO, April 30, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) ("Skye"), a clinical-stage biotechnology company focused on the discovery, development and commercialization of nov

GlobeNewswireApr 30 07:00 ET

Skye Bioscience to Present at Upcoming Investment Conferences

SAN DIEGO, April 23, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (NASDAQ:SKYE) ("Skye"), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel classes of

GlobeNewswireApr 23 07:00 ET

Why Super Micro Computer Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Shares of Super Micro Computer, Inc. (NASDAQ:SMCI) fell sharply during Friday's session.The company announced its third-quarter earnings date and did not provide preliminary estimates as it did with t

BenzingaApr 19 13:25 ET

Top 10 Stocks With Upwards and Downwards Daily Percentage Change - Piper Sandler

Seeking AlphaApr 12 11:34 ET

Skye Bioscience Initiated at Outperform by Oppenheimer

Skye Bioscience Initiated at Outperform by Oppenheimer

Dow JonesApr 12 05:37 ET

Express News | Skye Bioscience Inc : Oppenheimer Initiates Coverage With Outperform Rating; Target Price $25

Moomoo 24/7Apr 12 05:13 ET

Skye Bioscience to Uplist to Nasdaq Global Market

Seeking AlphaApr 10 08:09 ET

Skye Bioscience Stock Target Raised to $20 on Study Progress

On Thursday, Skye Bioscience Inc. (OTC: SKYE) saw its price target increased to $20 from $12 by a Piper Sandler analyst, who also reaffirmed an Overweight rating on the stock.

Investing.com Mar 14 10:56 ET

Piper Sandler Reiterates Overweight on Skye Bioscience, Raises Price Target to $20

Piper Sandler analyst Edward Tenthoff reiterates Skye Bioscience with a Overweight and raises the price target from $12 to $20.

Analyst UpgradesMar 14 10:30 ET

Skye Bioscience Announces $40 Million Private Placement Equity Financing

Yahoo FinanceMar 11 09:20 ET

Skye Bioscience Appoints Dr. Annalisa Jenkins to Board of Directors

SAN DIEGO, March 04, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB:SKYE) ("Skye" or the "Company"), a clinical-stage biotechnology company focused on the discovery, development and

GlobeNewswireMar 4 07:00 ET

Medical Marijuana Market Expected to Grow at 22% CAGR Through 2027

Seeking AlphaMar 2 13:04 ET